KAMRA CORNEAL INLAY

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2018-10-04 for KAMRA CORNEAL INLAY manufactured by Corneagen.

Event Text Entries

[122798388] The lack of visual and dimensional information is attributed to the singapore national eye centre (snec) that the patient went to for the check-up. After explant, the snec histology department took the kamra inlay for analysis. Post analysis the inlay was discarded. Attached as "annex a" is the resulting report for the snec histology department. The patient has suffered some level of hyperopic shift due to the explant; with a slightly melted inlay, removal of some corneal tissue was deemed necessary. The laser used during the aesthetic facial treatment was a nd:yag laser. No safety glasses were worn during the procedure. Details of the laser's pulse, energy, and duration during treatment can be found in annex a. In south korea in early 2014 a similar case was documented by acufocus, inc. As complaint (b)(4). As a result, acufocus issued two field safety notices related to the use of ophthalmic lasers with the kamra inlay implanted. The first in 2014; the second in 2015 with added content on laser based glaucoma therapy. Both field safety notices can be found at the end of this document. In the kamra instructions for use (accessible on the fda website) under section 2. 3 potential risks of the kamra inlay there is a subsection indicating risks with use of laser treatments: "laser treatments. There are potential risks of damaging the cornea and/or inlay with the use of some medical lasers with longer wavelengths (650 nm or more) and the lasers in the infrared spectrum are most likely to cause thermal damage to the inlay and surrounding corneal tissue. Thermal scarring has been reported resulting from lasik flap creation with a femtosecond laser and photodynamic therapy. (mita m, et al, 2013) overlapping of the laser beam and the inlay annulus can also result in the release of pigmented carbon granules from the inlay into the corneal tissue. " given that a similar case has occurred in the past, two field safety notices were released, and the instructions for use caution the use of lasers near the kamra inlay, this is an incident of known risk.
Patient Sequence No: 1, Text Type: N, H10


[122798389] Year five post-kamra operation the patient was noted as being happy with the kamra inlay. However, the patient went to a medical aesthetics clinic to have laser treatment for facial skin tightening and eyelid rejuvenation (non-ablative skin treatment). Post aesthetic laser treatment the patient suffered deteriorating visual acuity and went to the singapore national eye centre for treatment. Damage to the kamra inlay was noted and led to explant on (b)(6) 2018.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005357288-2018-00004
MDR Report Key7935267
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2018-10-04
Date of Report2018-10-03
Date of Event2018-06-11
Date Facility Aware2018-09-05
Report Date2018-09-05
Date Reported to Mfgr2018-09-05
Date Added to Maude2018-10-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactBENJAMIN STEINBERG
Manufacturer Street101 N. CHESTNUT ST. STE. 303
Manufacturer CityWINSTON SALEM 27101
Manufacturer CountryUS
Manufacturer Postal27101
Manufacturer Phone3365169640
Manufacturer G1CORNEAGEN
Manufacturer Street101 N. CHESTNUT ST. STE. 303
Manufacturer CityWINSTON SALEM 27101
Manufacturer CountryUS
Manufacturer Postal Code27101
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameKAMRA CORNEAL INLAY
Generic NameKAMRA INLAY
Product CodeLQE
Date Received2018-10-04
Lot NumberA234-0611
Device Expiration Date2013-06-01
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Age7 YR
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCORNEAGEN
Manufacturer Address101 N. CHESTNUT ST. STE. 303 WINSTON SALEM 27101 US 27101


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-10-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.